1. Volume 59, Issue 4, Pages 509-514 (April 2011)
Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer 
Antonio Finelli, Greg Trottier, Nathan Lawrentschuk, Robert Sowerby, Alexandre R. Zlotta, Lenny Radomski, Narhari Timilshina, Andrew Evans, Theodorus H. van der Kwast, Ants Toi, Micheal A.S. Jewett, John Trachtenberg, Neil E. Fleshner 
European Urology 
Volume 59, Issue 4, Pages (April 2011)
DOI: /j.eururo
Copyright © Terms and Conditions

2. Fig. 1
Kaplan-Meier analysis of (A) time to pathologic progression and (B) time to active treatment for patients on active surveillance for prostate cancer who are taking a 5α-reductase inhibitor (5-ARI) or not.
European Urology  , DOI: ( /j.eururo )
Copyright © Terms and Conditions